Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fujii

Showing results (901-910 of 903) with videos related to

Pageof 91
Sort By:
You have reached the last page of results.This site can display upto 903 results.
Allergy|December 3, 2017
Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide studyH Tanaka, E Nakatani, Y Fukutomi, et al.
BMC Cancer|May 7, 2017
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II studyT Yokota, T Ogawa, S Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1982
[Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer]Y Inuyama, I Hiroto, C Taketa, et al.
Pageof 91

Showing results (901-910 of 903) with videos related to

Sort By:
Pageof 91
You have reached the last page of results.This site can display upto 903 results.
Allergy|December 3, 2017
Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide studyH Tanaka, E Nakatani, Y Fukutomi, et al.
BMC Cancer|May 7, 2017
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II studyT Yokota, T Ogawa, S Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1982
[Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer]Y Inuyama, I Hiroto, C Taketa, et al.
Pageof 91